INCOME TAXES (Tables)

12 Months Ended

Oct. 31, 2025

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]

The components of income before income taxes and noncontrolling interests are as follows (in thousands):

	Year ended October 31,
	2025	2024	2023
Domestic	$814,178	$596,060	$479,990
Foreign	79,376	81,526	75,293
Income before taxes and noncontrolling interests	$893,554	$677,586	$555,283

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]

The components of the provision for income taxes on income before income taxes and noncontrolling interests are as follows (in thousands):

	Year ended October 31,
	2025	2024	2023
Current:
Federal	$148,908	$97,164	$96,492
State	23,114	19,195	18,225
Foreign	24,543	24,143	22,714
	196,565	140,502	137,431
Deferred:
Federal	(38,000)	(17,038)	(19,049)
State	(7,615)	(2,911)	(4,311)
Foreign	(2,950)	(2,053)	(3,171)
	(48,565)	(22,002)	(26,531)
Total income tax expense	$148,000	$118,500	$110,900

Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]

A reconciliation of the federal statutory income tax rate to the Company’s effective tax rate is as follows:

	Year ended October 31,
	2025		2024		2023
Federal statutory income tax rate	21.0	%	21.0	%	21.0	%
State taxes, net of federal income tax benefit	2.0	%	2.5	%	2.5	%
Tax benefit related to stock option exercises	(3.0	%)	(2.0	%)	(1.1	%)
Foreign-derived intangible income deduction	(2.5	%)	(2.4	%)	(1.9	%)
Research and development tax credits	(1.8	%)	(2.1	%)	(1.9	%)
Tax-exempt gains on corporate-owned life insurance policies	(1.2	%)	(2.3	%)	(.6	%)
Nondeductible compensation	1.3	%	2.2	%	1.4	%
Other, net	.8	%	.6	%	.6	%
Effective tax rate	16.6	%	17.5	%	20.0	%

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]

Significant components of the Company’s deferred tax assets and liabilities are as follows (in thousands):

	As of October 31,
	2025	2024
Deferred tax assets:
Inventories	$107,395	$92,498
Deferred compensation plan liability	67,433	57,016
Capitalized research and development costs	65,424	48,820
Operating lease liabilities	28,384	28,270
Contract liabilities (deferred revenue)	15,724	6,146
Share-based compensation	14,797	11,387
Performance-based compensation accrual	10,060	8,183
Other	18,030	21,657
Total deferred tax assets	327,247	273,977
Deferred tax liabilities:
Goodwill and other intangible assets	(358,691)	(330,624)
Property, plant and equipment	(45,834)	(27,701)
Operating lease right-of-use assets	(27,022)	(26,766)
Other	(2,886)	(3,042)
Total deferred tax liabilities	(434,433)	(388,133)
Net deferred tax liability	($107,186)	($114,156)

Schedule of Unrecognized Tax Benefits Roll Forward

A reconciliation of the activity related to the liability for gross unrecognized tax benefits during fiscal 2025 and 2024 is as follows (in thousands):

	Year ended October 31,
	2025	2024
Balance as of beginning of year	$6,451	$4,363
Increases related to current year tax positions	3,182	2,521
Increases related to prior year tax positions	—	88
Decreases related to prior year tax positions	(120)	—
Lapses of statutes of limitations	(628)	(521)
Balance as of end of year	$8,885	$6,451